September 20, 2014 10:21 PM ET

Capital Markets

Company Overview of Ampersand Capital Partners

Company Overview

Ampersand Capital Partners is a private equity firm specializing in growth equity investments in middle market and buyout companies. The firm typically invests in healthcare and industrial sector. Within Industrial sector, it focuses on product and process design software, instrumentation for the chemical processing and environmental industries. Within healthcare sector, the firm focuses on, life sciences, pharmaceuticals, and biotechnology sectors. It typically invests between $10 million and $50 million per deal in companies with revenues between $10 million and $100 million. The firm prefers to be the first and lead institutional investor in its portfolio companies. Ampersand Capital Part...

55 William Street

Suite 240

Wellesley, MA 02481

United States

Founded in 1988

Phone:

781-239-0700

Fax:

781-239-0824

Key Executives for Ampersand Capital Partners

Founder and Managing Partner
Age: 62
Chief Financial Officer and Chief Compliance Officer
Director of Operations
Managing Partner and Managing General Partner
Age: 49
General Counsel
Age: 52
Compensation as of Fiscal Year 2014.

Ampersand Capital Partners Key Developments

Ampersand Capital Partners Adds Cecil Kost as Operating Partner

Ampersand Capital Partners announced the addition of Cecil Kost as an Operating Partner. Cecil will work with the Ampersand investment team to identify and evaluate new platform opportunities as well as assist on the existing portfolio. Most recently he served as President and CEO of Precision Dynamics Corp.

Ampersand Capital Partners Expands Management Team

Ampersand Capital Partners announced three additions to its management team. Eric Lev has joined the company as a partner, bringing over 12 years of middle market healthcare investing experience. Eric was most recently at Water Street Healthcare Partners where he served on the investment team since Water Street's formation in 2005. Prior to Water Street, Eric worked at Beckman Coulter and at One Equity Partners. Dana Niles has joined as the firm's CFO and Chief Compliance Officer. Prior to Ampersand, Dana served as CFO of HighPoint Capital. Before HighPoint, Dana served as Controller at both HLM Venture Partners and YankeeTek Ventures and as a Senior Auditor at Arthur Andersen. John Perkins has joined the company as an Operating Partner, where he will work with the investment team to identify and evaluate new platform opportunities. Most recently, John served as a senior executive at Talecris Biotherapeutics. Prior to Talecris, John held roles as an operating executive at Cerberus and as an executive at General Electric.

Similar Private Companies By Industry

Company Name Region
Harborview Capital Management, LLC, Investment Banking Arm United States
KLR Group Holdings, LLC, Research Division United States
Independence Capital Co., Inc. United States
Kidron Capital Advisors LLC United States
Hankin & Co. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 9, 2014
Viracor-IBT Laboratories, Inc.
Merger/Acquisition
February 19, 2014
Kortec, Inc.
Private Placement
December 17, 2013
Nutramed, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ampersand Capital Partners, please visit www.ampersandcapital.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.